| Heading: |
Osteoporosis: Drugs |
| Question ID: |
1792397 |
| UIN: |
HL6545 |
| House: |
Lords |
| Date tabled: |
2025-04-03 |
| Asking Member ID: |
4171 |
| Asking Member display name: |
Lord Black of Brentwood
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Lord Black of Brentwood
|
| Member interest: |
false |
| Question text: |
To ask His Majesty's Government what steps they are taking to ensure that all medicines approved for treatment of osteoporosis by the National Institute for Health and Care Excellence are available in (1) integrated care systems and (2) local formularies. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-04-09 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
347 |
| Answering Member display name: |
Baroness Merron
|
| Answering Member handle: |
|
| Answering Member Twitter reference: |
Baroness Merron
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The National Institute for Health and Care Excellence (NICE) makes recommendations for the National Health Service on whether new licensed medicines should be routinely funded by the NHS based on an assessment of their costs and benefits.The NHS in Englan... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |